Directory Category: Drug Delivery
MetP Pharma’s Neural Targeting Drug Delivery Technology Sets a New Benchmark for Brain Delivery of Peptides
Intranasal nose-to-brain delivery achieves superior brain exposure with low systemic burden, outperforming transporter-based BBB technologies in preclinical studies 29 January 2026 — Emmetten, Switzerland — MetP...
Read MoreMetP Pharma’s Enabling Technology Creates a New Brain-Targeted GLP-1 Opportunity
Preclinical data in rats demonstrate dose-dependent and rapid brain targeting of intranasal semaglutide with low systemic exposure 22 January 2026 — Emmetten, Switzerland — MetP Pharma AG, a pioneer in nose-to-brain...
Read MoreJemperli®▼(dostarlimab) with platinum-based chemotherapy to be made available on the NHS for all eligible patients in England for first-line treatment of primary advanced or recurrent endometrial cancer
Jemperli (dostarlimab) with platinum-based chemotherapy to be made available on the NHS for all eligible patients in England for first-line treatment of primary advanced or recurrent endometrial cancer Following a positive...
Read More
